Thursday, November 13, 2014

The risk for coronary artery disease is two to four times higher in diabetic subjects

Indians get diabetes on average 10 years earlier than their Western counterparts

Being an Indian is a risk factor for diabetes; despite having lower overweight and obesity rates, India has a higher prevalence of diabetes compared to western countries and the risk for coronary artery disease is two to four times higher in diabetic subjects,  and in Indians, and it occurs prematurely are a few of the facts compiled by Heart Care Foundation of India to create awareness about how to control the diabetic menace in India.


All the public, private and government sector should fight the diabetic menace epidemic menace together, said Padma Shri, National Science Communication and Dr B C Roy National Awardee, Dr KK Aggarwal President Heart Care Foundation of India and Senior National Vice President Indian Medical Association.

Diabetes  challenges for India and Indians as compiled by the foundation

1.    Diabetes is a huge problem in India. The prevalence of diabetes increased tenfold, from 1.2% to 12.1%, between 1971 and 2000. It is estimated that 61.3 million people aged 20-79 years live with diabetes in India (2011 estimates). This number is expected to increase to 101.2 million by 2030. And, 77.2 million people in India are said to have pre-diabetes.


2.     Rough estimates show that the prevalence of diabetes in rural populations is one-quarter that of urban population for India and other Indian sub-continent countries such as Bangladesh, Nepal, Bhutan, and Sri Lanka.  An ICMR study has shown that a lower proportion of the population is affected in states of Northern India (Chandigarh 0.12 million, Jharkhand 0.96 million) as compared to Maharashtra (9.2 million) and Tamil Nadu (4.8 million). The National Urban Survey conducted across the metropolitan cities of India reported similar trend: 11.7 per cent in Kolkata (Eastern India), 6.1 per cent in Kashmir Valley (Northern India), 11.6 per cent in New Delhi (Northern India), and 9.3 per cent in West India (Mumbai) compared with (13.5 per cent in Chennai (South India), 16.6 per cent in Hyderabad (south India), and 12.4 per cent Bangalore (South India).


3.    Obesity is one of the major risk factors for diabetes, yet there has been little research focusing on this risk factor across India. Despite having lower overweight and obesity rates, India has a higher prevalence of diabetes compared to western countries suggesting that diabetes may occur at a much lower body mass index (BMI) in Indians compared with Europeans.


4.     A most disturbing trend is the shift in age of  onset of diabetes to a younger age. Indians get diabetes on average 10 years earlier than their Western counterparts.  An upsurge in number of early-onset diabetes cases is also responsible for the development of various diabetic complications due to longer disease duration. Diabetes control in individuals worsened with longer duration of the disease (9.9±5.5 years), with neuropathy the most common complication (24.6 per cent) followed by cardiovascular complications (23.6 per cent), renal issues (21.1 per cent), retinopathy (16.6 per cent) and foot ulcers (5.5 per cent).


5.     The risk for coronary artery disease is two to four times higher in diabetic subjects,  and in Indians, and it occurs prematurely. Indians are genetically predisposed to the development of coronary artery disease due to dyslipidaemia and low levels of high density lipoproteins; these determinants make Indians more prone to development of the complications of diabetes at an early age (20-40 years) compared with Caucasians (>50 years) and indicate that diabetes must be carefully screened and monitored regardless of patient age within India. The rate of cardiovascular disease mortality in India in the 30-59-year age group is double that in the U.S.


6.     Lifestyle changes have lead to decreased physical activity, increased consumption of fat, sugar and  calories, and higher stress levels, affecting insulin sensitivity and obesity. 86% of adults consume less than five servings of fruits and vegetables a day. 18.    Many Indians have insufficient physically activity (26.4% among males and 25.6% among females).


7.     Costs of diabetes care are alarmingly high. The annual cost for India due to diabetes was about $38 billion in 2011. According to the WHO, if one adult in a low-income family has diabetes, “as much as 25% of family income may be devoted to diabetes care.”   According to the World Economic Forum, cardiovascular disease, cancer, chronic respiratory disease,  diabetes and mental health conditions will cost India 126 trillion rupees between 2012 and 2030.


8.     While HbA1c is the gold standard test around the world for insulin initiation and intensification, it is not easily available to a large section of Indian population.


9.     There is a lack of “clinical inertia” for the commencement of insulin therapy in both the clinical and patient communities. The most common apprehensions are related to the complexities of the insulin regimen and concerns about weight gain, hypoglycaemic events, and fear of insulin prick.


10.     An inadequacy in Indian guidelines is also responsible for wide variation in treatment preferences across the country. The creation of simple and practical insulin guidelines that can be incorporated into routine clinical practice by primary health care physicians are desperately required to facilitate treatment and the initiation of insulin therapy throughout the country. Poor glycaemic control, a factor that has been observed in the Indian diabetic population, is responsible for micro- and macrovascular changes that present with diabetes
    

Monday, November 10, 2014

Eating a healthy breakfast decreases the risk of developing type 2 diabetes

Eating a healthy breakfast decreases the risk of developing type 2 diabetes


New Delhi: World Diabetes Day is celebrated annually on November 14. Led by the International Diabetes Federation (IDF), World Diabetes Day was created in 1991 by IDF and the World Health Organization in response to growing concerns about the escalating health threat posed by diabetes.

Healthy Living and Diabetes is the World Diabetes Day theme for this year with focus on the importance of starting the day with a healthy breakfast to help prevent the onset of type 2 diabetes and effectively manage all types of diabetes to avoid complications.

"Eating a healthy breakfast decreases the risk of developing type 2 diabetes", said Padma Shri, National Science Communication and Dr B C Roy National Awardee, Dr KK Aggarwal president Heart Care Foundation of India and Senior National Vice President Indian Medical Association.

"A healthy diet is, more expensive than an unhealthy one. The wide availability of cheap energy dense low-nutrient food is contributing to the global epidemic of type 2 diabetes. Foods which reduce the risk of type 2 diabetes such as vegetables, fresh fruit, whole grains and unsaturated fats need to be more affordable and more widely available", added Dr Aggarwal.

A healthy diet containing leafy vegetables, fresh fruit, whole grains, lean meat, fish and nuts  can help reduce a person’s risk of type 2 diabetes  and avoid complications in people with diabetes.

Diabetes is a huge and growing burden: while 382 million people were living with diabetes  in 2013 that number is expected to balloon to  almost 600 million people by 2035. Diabetes is fast gaining the status of a potential epidemic in India with more than 62 million diabetic individuals currently diagnosed with the disease.
Up to 11% of total healthcare expenditure in every country across the globe could be saved by tackling the preventable risk factors for type 2  diabetes and over 70% of type 2 diabetes cases can be prevented or delayed by adopting healthier 
lifestyles. 


Saturday, November 8, 2014

Verapamil can reverse Diabetes

Verapamil can increase the beta cell mass: Verapamil, a drug used to control high blood pressure and arrhythmias has been shown by Dr Anath Shalev at University of Birmingham, Alabama to not only prevent type 1 diabetes in mice but reverse severe established diabetes. The drug down regulates a key promoter of type 1 diabetes (thioredoxin-interacting protein ) and bolster whatever dysfunctional beta cells remain in the pancreas. The treatment definitely creates an environment where beta cells are allowed to survive.

And now one year human trial, entitled, "The repurposing of verapamil as a beta-cell survival therapy in type 1 diabetes," is expected to begin early in 2015 by the same group.

Over a decade ago, the UAB team was able to identify a protein called thioredoxin-interacting protein (TXNIP), which is dramatically increased in human islet cells in response to high glucose levels. The researchers hypothesized that TXNIP might be involved in beta-cell death associated with diabetes. 

  Even short-term postprandial glucose excursions, as seen in pre-diabetes, may lead to a gradual, cumulative increase in TXNIP expression before any onset of overt diabetes. Furthermore, insulin resistance or any increased demand on the beta cell may also lead to elevated beta-cell TXNIP levels.
The team showed that TXNIP does indeed induce beta-cell death by apoptosis: in mice models in which TXNIP had been genetically deleted, for example, the animals were completely protected against diabetes.

Reduction of intracellular calcium inhibits the transcription and expression of TXNIP, so by using the calcium-channel blocker Verapamil to do this, they were able to mimic the effects of genetically deleted TXNIP in mice and preserve the insulin-producing beta cells.

Even after the animals had developed full-blown diabetes with high blood sugar levels, when treated with Verapamil, blood sugars normalized, and this was due to the reappearance and normalization of insulin-producing beta cells. [Mol Endocrinol. 2014:28:1211-1220]

Note: In India use of Verapamil in diabetes will be an off label use and hence will require consent. However those with high blood pressure or with hear blockages can be shifted to Verapamil.'


Friday, November 7, 2014

Non obstructive heart blockages not benign : Dr K K Aggarwal


In a retrospective study of patients undergoing elective coronary angiography, non-obstructive coronary artery disease (heart blockages), compared with no apparent coronary artery disease ( no blockages), was associated with a significantly greater 1-year risk of heart attack and all-cause mortality.


After risk adjustment, there was no significant association between 1- or 2-vessel non-obstructive coronary artery disease ( blockages in one or two arteries) and mortality, but there were significant associations with mortality for 3-vessel non-obstructive coronary artery disease (blockages in all three arteries).


Veterans with evidence of non-obstructive CAD on elective coronary angiography had a 2- to 4.5-fold greater risk for heart attack compared with those with no evidence of blockages and 1-year heart attack risk was found to increase progressively by the extent of blockages, rather than increasing abruptly when blockages became obstructive.
The results of this study are published in Nov. 5 JAMA.


Never tell your patients " that your coronaries are fine and they have nothing to worry about," but one should say " 'There is evidence of atherosclerosis and while there is no need to panic, we need to address it.'" Remember there is nothing like " mild coronary artery disease or mild blockages in the heart."

Up to 1 in 4 Angiograms Show Minimal Plaque or blockages.

Non-obstructive blockages mans presence of atherosclerotic plaque revealed during coronary angioplasty or angiography that does not appear to obstruct blood flow or result in angina symptoms.

These non-obstructive lesions occur in between 10% and 25% of patients undergoing elective angiography, and their presence has historically been characterized as "insignificant" or "no significant blockages  in the medical literature even though multiple studies have shown plaque ruptures leading to heart attack commonly come from non-obstructive plaques.

Thursday, November 6, 2014

Recurrent Kidney Stones: IMA Guidelines

Recurrent Kidney Stones: IMA Guidelines


Lifetime prevalence of kidney stones is approximately 13% in men and 7% in women. Without treatment, approximately 35% to 50% of those with kidney stones will experience recurrence within 5 years from the first stone.


Here are some guidelines


1. Increasing fluid intake to achieve at least 2 L of urine per day. "Increased fluid intake spread throughout the day can decrease stone recurrence by at least half with virtually no side effects. However, people who already drink the recommended amount of liquids, or when increased fluid intake is contraindicated, should not increase their fluid intake.

2. Available evidence shows no difference between intake of tap water or intake of a specific brand of mineral water in preventing kidney stones.

3. If drinking increased amounts of water is ineffective in preventing kidney stones, one may try pharmacologic monotherapy with a thiazide diuretic, citrate, or allopurinol.  These three types of drugs effectively reduced recurrence of composite calcium stones in patients who had a history of two or more stones. Combination therapy is no more effective than monotherapy.  All these drugs were associated with adverse events. For thiazides, these were orthostasis, gastrointestinal upset, erectile dysfunction, fatigue, and muscle symptoms. Citrates are associated with gastrointestinal symptoms and allopurinol with rash, acute gout, and leukopenia.

4. Patients should reduce intake of colas and other soft drinks acidified with phosphoric acid, as lower consumption is linked to lower risk for stone recurrence.

5. Fruit-flavored soft drinks can be taken as they are often acidified with citric acid.

6. Patients should reduce consumption of dietary oxalate, typically found in chocolate, beets, nuts, rhubarb, spinach, strawberries, tea, and wheat bran.

7. Patients should eat less dietary animal protein and purines.

8. Patients should maintain normal dietary calcium.

[ Contributor: Padma Shri, Dr B C Roy National Awardee and National Science Communication Awardee Dr K K Aggarwal, Honorary Secretary General IMA]

[Reference: November 4 issue of the Annals of Internal Medicine]

Wednesday, November 5, 2014

No heart patient should take antibiuotics without supervision: Dr K K Aggarwal


Antibiotic Cotrimoxazole when Combined With ACE Inhibitor or ARB can end up with Sudden Death

Trimethoprim-Sulfamethoxazole May Increase Risk for Hyperkalemia in the Elderly


New Delhi: In a study published in BMJ, the risk of sudden death went up by more than a third in older patients taking ACE inhibitors or angiotensin-receptor blockers (ARBs) who were also put on the antibacterial agent cotrimoxazole (sulfamethoxazole and trimethoprim), compared with those who were instead given amoxicillin.

The elevated risk was likely caused by its capacity for raising serum potassium, which became fatal on top of other medications known for causing hyperkalemia.

Patients who are on ACE inhibitors or ARBs, are at risk for hyperkalemia, should not take any antibiotic without medical supervision.

If given


1. One should give it at the lowest dose and for a minimum period of time
2. And keep a watch on potassium.


Diabetics are vulnerable


Patients with type 2 diabetes have a tendency for hyperkalemia because od silent kidny involvement
Heart failure patients if on potassium-sparing spironolactone are also at risk
Patients with both reduced left ventricular function and diabetes have the greatest risk.

The risk, he said, depends on the antibiotic's dosage and duration of use. Ten days of cotrimoxazole may be risky while three days not.
In the study data from patients aged 66 or older who received ACE inhibitors or ARBs in Ontario from 1994 to 2012, identified outpatients who died of sudden death within 7 days of being prescribed cotrimoxazole, amoxicillin, ciprofloxacin, norfloxacin, or nitrofurantoin. Those 1027 cases were matched to 3733 controls alive within that time frame relative to the antibiotic prescriptions, based on, among other things, age, sex, chronic kidney disease, and diabetes.

The adjusted odds ratios (95% CI) for sudden death within 7 days of an antibiotic prescription on top of an ACE inhibitor or ARB, by antibiotic, relative to amoxicillin (which does not pose a hyperkalemia risk itself or prolong the QT interval) were: 1.38 for cotrimoxazole; 1.29 for ciprofloxacin; 0.74 for norfloxacin and 0.64 for nitrofurantoin.

Ciprofloxacin can predispose to sudden death by prolonging the QT interval.

Tuesday, November 4, 2014

Type 2 diabetes can be delayed or prevented

Type 2 diabetes can be delayed or prevented, and both types 1 and 2 diabetes can be managed to prevent complications.


India is the diabetic capital of the world.


People with diabetes are nearly two times more likely than people without diabetes to die from heart disease, and are also at greater risk for kidney, eye and nerve diseases, among other painful and costly complications. Type 2 diabetes can be delayed or prevented, and both types 1 and 2 diabetes can be managed to prevent complications.


The National Diabetes Month, include World Diabetes Day on Nov. 14.


In type 1 diabetes, the body does not make insulin. In type 2 diabetes the body does not make or use insulin well. Gestational diabetes, occurs in some women during pregnancy. Though it usually goes away after the birth, these women and their children have a greater chance of getting type 2 diabetes later in life.


Type 2 diabetes has begun to affect young people.


Losing a modest 15 pounds of weight through diet and exercise can actually cut your risk of getting type 2 diabetes by as much as 58 percent in people at high risk.


In type 1 diabetes, tight control of blood sugar can prevent diabetes complications.


Diabetes Tips


·         Choose healthy foods to share.
·         Take a brisk walk together every day.
·         Talk with your family about your health and your family’s risk of diabetes and heart disease.
·         If you smoke, seek help to quit.
·         Make changes to reduce your risk for diabetes and its complications — for yourself, your families and for future generations.